Read the latest positive news, breakthroughs, and inspiring stories about lung cancer research, curated daily by BrightWire.
A groundbreaking six-year study aims to solve one of cancer treatment's biggest puzzles: predicting which lung cancer patients will respond to immunotherapy. With $23.7 million in federal funding, City of Hope is mapping how tumors change to help doctors choose the right treatment from the start.
Researchers at the University of Florida have discovered the first compound that effectively targets a specific protein that drives lung cancer, potentially opening new treatment options for patients. After screening nearly 700 molecules, they found one that kills cancer cells 100 to 200 times more selectively than existing options.
Researchers discovered a protein that helps lung cancer cells survive chemotherapy, opening the door to smarter treatments that could prevent deadly relapses. The breakthrough gives hope to patients facing one of cancer's toughest challenges.
Japanese researchers have captured the first real-time footage of lung cancer drugs physically reshaping disease-causing proteins, revealing why some treatments eventually stop working. The breakthrough could help doctors design better therapies that overcome drug resistance.